Stockreport

Sol-Gel Announces Positive Topline Results from Open-Label, Long-Term Safety Study of Epsolay® for Treatment up to 52 Weeks

Sol-Gel Technologies Ltd.  (SLGL) 
Last sol-gel technologies ltd. earnings: 11/13 07:05 am Check Earnings Report
PDF Successful topline results, strengthens Epsolay’s long-term safety and tolerability profile in the treatment of papulopustular rosacea Results pave the way for NDA subm [Read more]